CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity.
Ontology highlight
ABSTRACT: Metastatic progression and tumor evolution complicates the clinical management of cancer patients. Circulating tumor cell (CTC) characterization is a growing discipline that aims to elucidate tumor metastasis and evolution processes. CTCs offer the clinical potential to monitor cancer patients for therapy response, disease relapse, and screen 'at risk' groups for the onset of malignancy. However, such clinical utility is currently limited to breast, prostate, and colorectal cancer patients. Further understanding of the basic CTC biology of other malignancies is required to progress them towards clinical utility. Unfortunately, such basic clinical research is often limited by restrictive characterization methods and high-cost barrier to entry for CTC isolation and imaging infrastructure. As
SUBMITTER: Ffrench B
PROVIDER: S-EPMC9898658 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA